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Abstract
This work represents an update of knowledge regarding the detection methods for human microbiome-associated archaea. Despite the
fact that, during the last three decades, only four methanoarchaeal species have been isolated from the human mucosa, including faeces,
subgingival plaque, and vaginal mucosa (Methanobrevibacter smithii, Methanosphaera stadtmanae, Methanobrevibacter oralis and, most
recently, ‘Methanomassiliicoccus luminyensis’), molecular studies, including PCR and metagenomic analyses, have detected DNA sequences
indicative of the presence of additional methanoarchaea, as well as non-methanogenic archaea, in the human intestinal tract. Opinion is
divided on the roles (if any) of these organisms in human disease, and certainly the data are still unclear. Future research and recently
reported data highlighting the antimicrobial susceptibility of the human methanoarchaea could help in the design of selective media to
discover additional human mucosa-associated archaea and ascertain their role in human infections involving complex ﬂora.
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Introduction
Methanoarchaea represent a distinct group of anaerobic
archaea that produce methane under anaerobic conditions
[1]. In fact, in the anaerobic microniches where they have
been discovered, the activity of the primary microbial popu-
lations using available complex organic compounds leads to
the accumulation of H2 + CO2 and volatile fatty acids. For-
mate is rapidly converted via the formic hydrogenlyase to H2
and CO2, and may not be detectable, as it is rapidly metabo-
lized. The ultimate formation of methane and CO2 marks
the last step in a series of dissimilatory reactions in which
organic compounds are completely degraded. Methane is the
most reduced form of carbon, and CO2 the most oxidized
form of carbon [1,2]. Indeed, methane is one of the most
abundant greenhouse gases in the earth’s atmosphere, con-
stituting 18% of the global total and having a greenhouse
effect 25 times more efﬁcient than CO2 [3]. Methane is
mainly produced from ruminant livestock; therefore, several
studies have been conducted with the aim of limiting the
production of this gas by these animals [4,5].
Methanoarchaea have been also found to be part of the
intestinal microbiota in animals and humans, and even in
intracellular niches in some protists [6–16]. The most pre-
dominant methanoarchaeal species in human and animal
intestinal tracts belong to the genus Methanobrevibacter
[1,7,9,17]. A few other genera, such as Methanosphaera,
Methanosarcina, Methanobacterium, Methanomicrobium, Metha-
nogenium and, most recently, ‘Methanomassiliicoccus’, have
been also isolated from animals and humans [6,8,10,11,18–
20]. Methanoarchaea play a paramount role in the digestion
process and in preventing the accumulation of H2 and other
reaction end-products [21–24]. In fact, in anoxic conditions,
most gastrointestinal methanoarchaea, except members of
the genera Methanosphaera and ‘Methanomassiliicoccus’,
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obtain energy by reduction of CO2 to methane by using
hydrogen as the terminal electron acceptor [23]. Indeed,
Methanosphaera and ‘Methanomassiliicoccus’ species require
both H2 and methanol (oxidation of H2 and reduction of
methanol) to produce methane (Table 1) [8,20]. Besides H2,
Methanosarcina spp. may also use acetate, methanol,
monomethylamine, dimethylamine, trimethylamine, H2CO2,
and CO [25–27].
Although the precise ecological niches and the routes of
acquisition of archaea in humans remain largely unknown,
the environment is a likely source of human methanoarchaea.
In fact, Angel et al. [28] recently demonstrated that methan-
oarchaea are globally ubiquitous in aerated soils and become
active under wet anoxic conditions. These ﬁndings support
our hypothesis that the acquisition of some methanoarchaea
could occur through environmental contamination, and once
these organisms ﬁnd favourable physicochemical conditions
and available substrates in the gut, stable colonization is
established [29].
Studies on methanoarchaea started with classic bacterio-
logical culture isolation and quantiﬁcation methods [7,9,30].
More recently, molecular approaches have been developed
to provide an alternative means of investigating the gastroin-
testinal ecosystem without bacteriological culture methodol-
ogy [31–40], mostly because of the difﬁculty in isolating
fastidious anaerobes, and the long incubation times and strict
anaerobic cultivation methods needed, adding to the limited
knowledge of the nutritional requirements and antibiotic sen-
sitivity patterns of many methanoarchaea [29,30,41,42]. It
was generally believed that methanoarchaea were the only
group of archaea associated with the human mucosa, but
molecular approaches have demonstrated the presence of
some other archaeal groups in the human gastrointestinal
tract, such as Thermoplasma, Crenarchaeota, and halophilic
archaea [35,43–46].
We herein attempt to update the knowledge of the meth-
ods used during the last two decades to detect archaea in
association with the human mucosa, and the implication of
these methods for investigating the potential impact of these
organisms on human health and disease.
How to Detect Archaea in Humans
Direct microscopic examination
Auto-ﬂuorescence is an interesting feature of methanoar-
chaea, because they carry factor 420, causing blue–green
auto-ﬂuorescence when they are exposed to UV light at a
wavelength of 420 nm [47] (Fig. 1). Thus, methanoarchaeal
cells or colonies can be quickly identiﬁed by epiﬂuorescence
microscopy. This attribute has been and still is used in meth-
anogen growth monitoring [7,9,17,20,46].
Anaerobic cultivation
On the basis of the observation that people expired meth-
ane, Nottingham and Hungate [30] deduced that some met-
hanoarchaea could be present in the gut. The team
succeeded in isolating, for the ﬁrst time, methanoarchaea
from human faeces on non-selective medium in an anoxic
atmosphere with 80% H2 and 20% CO2 [30]. Combining the
preceding methods with the development of an anaerobic
chamber, Edwards and McBride [46] have proposed a new
method for the rapid growth and detection of methanoar-
chaea on Petri plates. Isolation of methanoarchaea from
complex specimens such as stools, dental plaque and envi-
ronmental samples was performed with the roll-tube tech-
nique according to Hungate [42] (Fig. 1). Miller et al. [9]
further isolated Methanobrevibacter smithii from human stool
specimens of four healthy adults by using anaerobic cultures
enriched with an H2/CO2 atmosphere (80 : 20) pressurized
TABLE 1. Morphological, phenotypic and G + C content of methanoarchaea isolated in humans
Methanoarchaea Methanobrevibacter smithii Methanobrevibacter oralis Methanomassiliicoccus luminyensis Methanosphaera stadtmanae
Source Human faeces Human subgingival plaque Human faeces Human faeces
Morphology Coccobacillary: single Short oval rods: pairs or short chains Cocci: single cell Cocci: pairs or tetrads
Diameter (lm) 1.5–2 0.7–1.2 0.7–1 1–1.2
Motility Non-motile Non-motile Non-motile Non-motile
Optimum temperature (C) 37 36–38 37 37
Optimum pH 6.7–7 6.9–7.4 7.6 6.5–6.9
Optimun NaCl concentration (g/L) ND 0.01–0.1 10 ND
DNA G + C content (mol. %) 31 28 59.93 27
Produce CH4 from H2 + CO2 and formate H2 + CO2 H2 + methanol H2 + methanol
ND, not determined.
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to 2 atm. A second methanoarchaeon isolated from human
faeces was Methanosphaera stadtmanae; Miller and Wolin [8]
have established that this archaeon requires H2 and methanol
for growth, and uses H2 to reduce methanol to methane. In
a further study, Belay et al. [48] succeeded in isolating strains
having antigenic similarity with M. smithii and Methanosphaera
stadtmanae from samples related to patients with some
degree of periodontal disease. Thereafter, anaerobic sampling
and culture of 12 vaginal specimens collected from eight
healthy women, three women with bacterial vaginosis and
one women with erosive lichen planus yielded methanoar-
chaea in only two of the specimens from patients with bacte-
rial vaginosis. Methanoarchaea were tentatively identiﬁed as
M. smithii on the basis of morphological, culture and immu-
nological characteristics [49]. Brusa et al. [17] also cultivated
methanoarchaea from the dental plaque of nine healthy sub-
jects who also harboured archaeal organisms in the faeces.
The third methanoarchaeon isolated in humans was Methano-
brevibacter oralis, which was isolated in 1994 from the subgin-
gival plaque of healthy individuals [2]. Finally, we most
recently isolated ‘Methanomassiliicoccus luminyensis’ from the
faeces of a healthy 86-year-old man; this archaeon exhibited
a similar type of metabolism to that of Methanosphaera
stadtmanae, by oxidizing H2 and reducing methanol to
methane, but requires tungsten to grow [20].
The major obstacle explaining the low number of met-
hanoarchaeal strains isolated until now from human samples
is most probably the limited knowledge of the nutritional
requirements and antibiotic sensitivity patterns of many
archaea [29,30]. In fact, the sensitivity of human-associated
archaea to antibiotics has, until recently, been investigated
in few studies, predominantly limited to methanogenic
strains of the gastrointestinal tract. Dermoumi and Ansorg
tested the sensitivity of 15 faecal isolates of M. smithii and
the reference strain DSM 861 to nine antibiotics. They con-
cluded that only metronidazole inhibited all strains at MICs
between 0.5 and 64 mg/mL [50]. These results were further
conﬁrmed by one subsequent study in bone marrow trans-
plant recipients, in which the use of metronidazole targeted
to faecal anaerobic bacteria also suppresses faecal methano-
archaea [51]. Following this work, and using the macrodilu-
tion method in Hungate tubes with optical microscope
observation combined with monitoring of methane produc-
tion (Fig. 1), we determined the antibiotic resistance charac-
teristics of the eight methanoarchaeal strains isolated in
humans for drugs of clinical interest and for squalamine,
which is a new potent antimicrobial agent reported to inhi-
bit fungi and both Gram-positive and Gram-negative bacte-
ria [52]. The antimicrobial susceptibility data that we
reported demonstrated the susceptibility of human methan-
oarchaea to only molecules also effective against both bac-
teria and eukaryotes, such as azoles and squalamine, in
agreement with their phylogenetic location as a unique
domain of life [53]. These results could help in the design
Specimen: stool, dental plaque,...
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FIG. 1. An organigram showing the main methods used for the detection, identiﬁcation and isolation of methanoarchaea from human samples.
MALDI-TOF, matrix-assisted laser desorption ionization time-of-ﬂight.
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of selective media for the isolation of new archaea from
the human-associated microbiota.
Molecular approaches
Recently, molecular methods have emerged as efﬁcient alter-
natives with which to investigate the prevalence of archaea
in human specimens and their potential association with
human disease [29]. On the basis of 16S rDNA sequencing,
many studies conﬁrmed that the human gastrointestinal tract
and oral cavity were dominated by Methanobrevibacter spe-
cies [19,31,33,35,54,55] (Fig. 2). They also established the
presence of M. smithii and Methanosphaera stadtmanae in the
human gut, with variable and low prevalence, and in most
cases a failure in Methanosphaera stadtmanae detection, in
addition to sequences corresponding to uncultured methano-
archaeal clones [29].
Besides 16S rDNA, the mcrA gene coding for a subunit of
methyl-coenzyme M reductase, a vital enzyme in methane
production, was used for the investigation of methanoar-
chaea in the human gut and oral cavity, and allowed the
detection of Methanosarcina plus Methanoculleus sequences, in
addition to M. smithii, Methanosphaera stadtmanae and Met-
hanobrevibacter oralis sequences, and sequences related to
uncultured methanoarchaea [19,31,35,36,56] (Fig. 2).
Metagenomic studies have also focused on archaeal pres-
ence in the human gastrointestinal tract, vagina, and oral cav-
ity, and have conﬁrmed the domination of Methanobacteriales
and, essentially, M. smithii [37–40,57–59] (Fig. 2). On the
basis of these data, the detection of M. smithii has been pro-
posed as an indicator of faecal contamination of potable
water [60].
In addition to methanoarchaea, conventional PCR yielded
16S rRNA sequences suggesting the presence of cre-
narchaeota, halophilic archaea and Thermoplasma organisms
in the human digestive ecosystem [31,35,38,43–45] (Fig. 2).
Gas chromatography
Gas chromatography is used to monitor methanoarchaeal
growth by detecting methane production rates [20,52].
Matrix-assisted laser desorption ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS)
MALDI-TOF MS has recently emerged as a rapid and cost-
effective technique for the identiﬁcation of bacteria, eukary-
otes, and giant viruses [61–66]. In the literature, only one
study has reported the usefulness of MALDI-TOF MS for the
identiﬁcation of environmentally extremophilic archaea,
belonging to quite distant phyla; these data were analysed
with respect to a limited range of spectra between 500 and
2000 Da [67]. Hence, we developed a speciﬁc protocol for
MALDI-TOF MS identiﬁcation of archaea, and applied it to
seven environmental human-associated strains of M. smithii,
M. oralis, Methanosphaera stadtmanae, and the recently
described ‘Methanomassiliicoccus luminyensis’. After mechanical
Methanomassiliicoccus luminyensis B10T
Thermoplasmatales
Putative new order
Euryarchaeota
Nanoarchaeota
Crenarchaeota
Korarchaeota
Methanosphaera
Methanobrevibater
Methanobacteriales
Methanosarcinales
Methanomicrobiales
Halobacteriales
Methanococcales
Archaeoglobales
Thermococcales
Bacteria, Eukarya, giant viruses
FIG. 2. Dendrogram depicting the major taxonomic groups of the Archaea. The dendrogram is based on representative 16S rRNA gene
sequences, and derived from sequence alignment with the neighbour-joining algorithm in Mega (http://www.megasoftware.net). Branches with tri-
angles correspond to genera with species previously detected or/and isolated in humans (red, detected and isolated in humans; green, sporadic
detection of 16S rRNA or mcrA genes in the human gut; blue, sporadic detection of 16S rRNA or mcrA genes in the human gut and oral cavity).
Note that this tree is not a rigorous phylogenetic analysis, but an attempt to convey the sequence relationships among archaeal organisms.
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lysis, we observed a unique protein proﬁle for each organ-
ism, comprising 7–24 peaks ranging from 3015 to 10 632 Da,
with a high quality score of 7.38 ± 1.26. Proﬁles were repro-
ducible over successive experiments performed at 1-week,
2-week and 3-week growth durations, and unambiguously
distinguished archaea from all of the three 995 bacterial
spectra in the Bru¨ker database. After the incorporation of
the determined proﬁles into a local database, archaeal iso-
lates were blindly identiﬁed within 10 min, with an identiﬁca-
tion score of 1.9–2.3. The MALDI-TOF MS-based clustering
of these archaeal organisms was consistent with their 16S
rDNA sequence-based phylogeny. The obtained data proved
that MALDI-TOF MS proﬁling could be used as a ﬁrst-line
technique for the identiﬁcation of human archaea [68]
(Fig. 1).
Contribution of Archaeal Detection in
Clinical Microbiology
Human gut
For determination of the contribution of active methanoar-
chaea to disease, most studies were based on measurement
of breath methane by gas chromatography. The relationship
between methanoarchaea in the colon and colonic vascular
circulation diseases has been investigated in patients with
aortoiliac and femoropopliteal diseases [69]. The proportions
of methane excretors in the control group and in those with
femoropopliteal disease were 43% and 30%, respectively; in
patients with aortoiliac pathology, the proportion of methane
excretors was signiﬁcantly higher (83%). As compared with
healthy patients, elevated rates of breath methane have been
detected in patients with ulcerative colitis, colonic polyposis,
and colon cancer [70]. Most recently, Basseri et al. [71] have
demonstrated that a higher concentration of methane
detected by breath testing is a predictor of signiﬁcantly
greater obesity in overweight subjects. This method is also
used for methanoarchaeal growth monitoring by detecting
methane production rates [20,52].
Scanlan et al. compared the incidence of methanoarchaeal
diversity in healthy and diseased colon groups through mcrA
gene analysis. They established a reduced methanoarchaeal
incidence in the inﬂammatory bowel disease groups: 24% for
ulcerative colitis, and 30% for Crohn’s disease [36]. On the
other hand, Samuel and Gordon demonstrated that methan-
oarchaea could enhance the activity and growth of polysac-
charide consumers such as members of the Bacteroidetes and
Firmicutes by removing H2 [72]. Thus, methanoarchaea indi-
rectly promote calorie intake by the body and, consequently,
accumulation of fat deposits, leading to obesity in individuals
on a high-ﬁbre diet. These results were further conﬁrmed by
comparing lean controls with obese patients before and after
gastric bypass; the authors observed an increase in Methano-
brevibacter load in obese patients [39].
By applying an improved DNA detection protocol based
on quantitative real-time PCR targeting 16S rRNA and rpoB
genes in a large number of specimens (650 individuals), we
recently established a high prevalence of the methanoarchaea
M. smithii (95.5%) and Methanosphaera stadtmanae (29.4%) in
the human gut, with the former being an almost ubiquitous
inhabitant of the intestinal microbiome [33].
Most recently, using the molecular system designed in the
last study [33], Armougom et al. obtained results in agree-
ment with those of Samuel and Gordon, reporting a 1.72-
fold increase in the M. smithii load in the obese group as
compared with the lean one; surprisingly, they observed a
signiﬁcantly higher M. smithii load in the anorexic population
than in lean patients (p 0.0171), and gave two possible rea-
sons for this—adaptive use of the very low calorie diet in
anorexic cases, or constipation, a common phenomenon in
anorexia nervosa patients [34].
Oral cavity
Several studies have principally focused on the role of oral
archaea in periodontal disease and endodontic infections.
Using PCR ampliﬁcation of archaeal 16S rDNA on pooled
subgingival plaque samples, Kulik et al. [73] found Methano-
brevibacter species in 37 of 48 cases of periodontal disease.
Quantitative PCR targeting archaeal 16S rDNA sequences
allowed Lepp et al. [74] to detect methanoarchaea, mostly
related to the genus Methanobrevibacter, in the lesion sites of
36% of tested patients, and to demonstrate the direct corre-
lation between the amount of methanoarchaea present in
the subgingival crevice and the severity of periodontitis. The
authors hypothesized that,. in periodontal pockets, methano-
archaea act syntrophically by serving as an H2 sink, and thus
favour the proliferation of pathogens. Through quantitative
real-time PCR based on the functional gene mcrA and on
archaeal 16S rRNA genes, Vianna et al. detected a methano-
genic pool dominated by M. oralis-like phylotypes in ﬁve of
20 necrotic uniradicular teeth with no previous endodontic
treatment. They estimated the size of archaeal population as
approximately 2.5% of the total prokaryotic community [54].
In a subsequent study, the same authors used an identical
molecular approach to perform a quantitative analysis of
methanoarchaea within plaque bioﬁlms associated with
human periodontal disease; they consistently detected hydro-
genotrophic groups in periodontal pockets with signiﬁcantly
elevated loads of methanoarchaea and sulphate reducers, and
conﬁrmed the impact of antagonistic interactions between
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H2 consumers and producers on the severity of periodontitis
[55]. Moreover, the authors established the presence of an
M. oralis-related phylotype in 44 periodontitis patients [55].
These results were conﬁrmed by subsequent studies using
similar molecular approaches; 16S rDNA sequences related
to an M. oralis-like species were detected in the root canals
of two patients, and it was established that archaea were
always found in combination with bacteria [75]. These results
reinforce the antagonism hypothesis. Most recently, Vianna
et al. performed a terminal restriction fragment length poly-
morphism-based mcrA gene analysis of methanoarchaea asso-
ciated with oral infections. They established a positive
association between methanoarchaea and Synergistes species,
and detected DNA of a novel Methanobrevibacter phylotype
in ﬁve periodontal samples and in one endodontic sample, in
addition to M. oralis [56].
By means of RT-PCR, based on universal archaeal 16S
rDNA sequences, Jiang et al. investigated the presence and
associations of archaea in primary and secondary root canal
infections. In primary infections, archaea were detected in 16
of 42 (38%) specimens, but in only six of 35 (17%) cases with
secondary root-infected canals [76].
Latterly, by combining archaeal 16S rRNA gene library
sequencing and quantitative PCR, Matarazzo et al. demon-
strated the presence of high levels of archaea and high archa-
eal/total prokaryote ratios in individuals with generalized
aggressive periodontitis as compared with periodontally
healthy subjects, indicating a possible role of some of these
microorganisms as environmental modiﬁers in generalized
aggressive periodontitis [77]. Similarly, by sequencing archa-
eal 16S rRNA gene libraries, Faveri et al. [78] demonstrated
an increased prevalence of archaea in peri-implantitis sites,
and suggested that the potential role of archaea in pathogen-
esis should be further investigated.
Perspectives
It is well established that archaea and, especially, methanoar-
chaea inhabit humans, and high numbers have been found in
the colon, mouth, and vagina. M. smithii, Methanosphaera sta-
dtmanae, M. oralis and ‘Methanomassiliicoccus luminyensis’ have
been, until now, the only four archaeal organisms isolated in
humans by culture approaches [2,7–9,17,48,49] (B. Dridi
et al., unpublished data). The prevalence and quantity of
human gut methanoarchaea have been underestimated for a
long time, undoubtedly because of the complicated nature of
their cultivation and the fact that standard protocols for
DNA extraction have not been optimized for such fastidious
microorganisms.
Although, until now, no archaea have been described as
being directly pathogenic, the occurrence in and coincidence
of these organisms, and especially methanoarchaea, with
diverse diseases and pathological conditions have raised many
unanswered questions concerning the role that they might
have in these pathologies. Many hypotheses have been for-
mulated to explain the possible contribution of methanoar-
chaea to diseases, and the most plausible is based on
syntrophic interactions with other microorganisms [79]. The
fact that methanoarchaea indirectly promote obesity indi-
cates potential stratagems to control either obesity, by inhi-
bition of methanoarchaea to decrease caloric intake, or
starvation-related weakness, by adding methanoarchaea to
the intestinal ﬂora.
Besides methanoarchaea, some other archaeal groups,
such as Thermoplasma, the Crenarchaeota, and halophilic ar-
chaea, have been transiently detected in human faeces
through the use of molecular tools such as PCR and me-
tagenomics [35,38,43–45]. Given the relative difﬁculty of
their isolation from stool samples, owing to their low pro-
portions, the role that these non-methanogenic archaea
may play in the human digestive tract is still unknown.
Their acquisition could also be accidental: for halophilic ar-
chaea-related DNA, the authors suggested the possibility
that the sequences obtained originated from pre-colonos-
copy saline lavage solutions [44]; and members of the Cre-
narchaeota have been found in fermented seafood [80]. In
fact, the most plausible explanation for the fact that most
archaea cannot colonize the human mucosa could be the
exceptionality of their biochemistry; they use a variety of
‘unusual’ cofactors that bacteria and eukaryotes neither
require nor produce [81]. Thus, from the standpoint of
nutritional requirements, the human mucosa could not con-
stitute a favourable environment for non-methanogenic ar-
chaea, because they are, as ‘biochemical outsiders’, inferior
regarding competition with bacteria.
In conclusion, the involvement of archaea in human dis-
ease and health warrants further investigation: ﬁrst, by com-
pleting the antimicrobial susceptibility patterns, by testing a
wide spectrum of antimicrobial agents, to improve isolation
conditions for such fastidious organisms and to develop new
families of molecules for the speciﬁc inhibition of archaea,
particularly with regard to the predicted potential role of
these organisms in human infections; and second, through
using adapted and speciﬁc approaches such as metagenomics
with high-throughput sequencing methods, PCR-based meth-
ods, microscopy, ﬂuorescence in situ hybridization, DNA
microarrays, and mass spectrometry, which are rapidly
emerging as powerful tools for the phenotypic detection of
many human pathogens [61,64,66,68,82–88].
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